Kevin T. Strange - Oct 1, 2024 Form 3 Insider Report for Inari Medical, Inc. (NARI)

Role: Chief Financial Officer
Signature: /s/ Shannon Trevino, attorney-in-fact for Kevin T Strange
Stock symbol: NARI
Transactions as of: Oct 1, 2024
Transactions value $: $0
Form type: 3
Date filed: 10/3/2024, 04:42 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NARI	Common Stock						47.4K	Oct 1, 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NARI	Stock Option							Oct 1, 2024	Common Stock	11.8K	$58.44	Direct	F1
holding	NARI	Stock Option							Oct 1, 2024	Common Stock	5.29K	$56.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These options were granted on February 15, 2024 under the Inari Medical, Inc. 2020 Incentive Award Plan and are scheduled to become vested and exercisable on a quarterly basis commencing April 1, 2024.
F2	These options were granted on February 18, 2023 under the Inari Medical, Inc. 2020 Incentive Award Plan and are scheduled to become vested and exercisable on a quarterly basis commencing April 1, 2023.